José Luis Cabriada

14PUBLICATIONS
101CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyCancer diagnosisAutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 31, 2025
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study.

Luis G Guijarro, Patricia de Castro-Martínez, María Chaparro

|Jan 09, 2025
Increased Medication Utilization Precedes Incidentally Diagnosed Inflammatory Bowel Disease: A Multicenter, Case-Control Study.

Iago Rodríguez-Lago, Urko Aguirre, Jose Luis Cabriada

|Jun 13, 2024
Transmural cross-sectional findings and bowel damage assessment in preclinical Crohn's disease: a case-control study.

Iago Rodríguez-Lago, Marta Aduna, Patricia Ramírez de la Piscina

|May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.

Celia Gómez-Labrador, Elena Ricart, Marisa Iborra

|Mar 28, 2024
Environmental Exposure to Trace Elements and Heavy Metals Preceding the Clinical Onset of Inflammatory Bowel Disease.

Iago Rodríguez-Lago, José Luis Cabriada, Ainhoa Rodríguez

|May 27, 2023
Development of a Prediction Model for Short-Term Remission of Patients with Crohn's Disease Treated with Anti-TNF Drugs.

Rosario Medina-Medina, Eva Iglesias-Flores, Jose M Benítez

Pageof 3